Patent Assignment
Reel/Frame 053548/0239
Confirmatory Grant of Security Interest in United States Patents
Recorded: 2020-05-26
Pages: 9
Assignors
ENDO GLOBAL VENTURES
Executed: 2020-05-13
ENDO VENTURES LIMITED
Executed: 2020-05-13
PALADIN LABS INC.
Executed: 2020-05-13
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(33)
Polymeric micelle compositions
Patent:
6,338,859 →
Application:
09/606,398 →
Cross-Linked High Amylose Starch for Use in Controlled-Release Pharmaceutical Formulations and Processes for Its Manufacture
Patent:
6,607,748 →
Application:
09/606,399 →
Water-Soluble Stabilized Self-Assembled Polyelectrolytes
Unimolecular Polymeric Micelles with an Ionizable Inner Core
Amphiphilic Diblock, Triblock and Star-Block Copolymers and Their Pharmaceutical Compositions
Preparation of Sterile Stabilized Nanodispersions
13C Glucose Breath Test for the Diagnosis of Diabetic Indications and Monitoring Glycemic Control
Ph-Sensitive Block Copolymers for Pharmaceutical Compositions
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Controlled-release compositions
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Compositions and Methods for Treating Collagen-Mediated Diseases
Process for the Preparation of Amphiphilic Poly(N-Vinyl-2-Pyrrolidone) Block Copolymers
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Narcotic Drug Formulations with Decreased Abuse Potential
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Method of Treating or Reducing EFP
Application:
14/255,407 →
Publication:
US 2014/0335072
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Compositions and Methods for Treating Collagen-Mediated Diseases
Application:
15/160,392 →
Publication:
US 2017/0087229
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Starch-Based Microparticles for the Release of Agents Disposed Therein
Application:
15/782,557 →
Publication:
US 2018/0193466
Solid Formulations of Liquid Biologically Active Agents
Method of Assessing and Treating Cellulite
Method of Producing Collagenase
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 27, 2020
From: YU, BO; WEGMAN, THOMAS L.
To: BIOSPECIFICS TECHNOLOGIES CORP.
Reel/Frame 053321/0701 →
Assignment of Assignor's Interest
Jul 27, 2020
From: ENDO GLOBAL VENTURES
To: ENDO GLOBAL AESTHETICS LIMITED
Reel/Frame 053321/0654 →
Assignment of Assignor's Interest
May 6, 2021
From: ISOTECHNIKA INC.
To: PALADIN LABS INC.
Reel/Frame 056160/0399 →
Change of Name
Jun 30, 2021
From: BIOSPECIFICS TECHNOLOGIES CORP.
To: BIOSPECIFICS TECHNOLOGIES LLC
Reel/Frame 056774/0545 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
Change of Name
Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
Change of Name
Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
Assignment of Assignor's Interest
Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
Assignment of Assignor's Interest
Apr 23, 2024
From: BIOSPECIFICS TECHNOLOGIES LLC
To: ENDO USA, INC.
Reel/Frame 067198/0623 →
Assignment of Assignor's Interest
Apr 23, 2024
From: PALADIN LABS INC.
To: PALADIN PHARMA INC.
Reel/Frame 067203/0281 →
Assignment of Assignor's Interest
Apr 23, 2024
From: ENDO GLOBAL AESTHETICS LIMITED
To: PALADIN PHARMA INC.
Reel/Frame 067198/0598 →
Release of Security Interest
Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0376 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067221/0958 →
Assignment of Assignor's Interest
Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0714 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0693 →
Assignment of Assignor's Interest
Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0736 →
Assignment of Assignor's Interest
Jun 20, 2024
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067778/0988 →
Change of Name
Jun 20, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 067994/0211 →
Assignment of Assignor's Interest
Jun 20, 2024
From: PALADIN LABS EUROPE LIMITED
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067779/0054 →
Security Interest
Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 068031/0059 →
Security Interest
Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068031/0202 →
Security Interest
Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest
Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 67245 Frame: 714. Assignor(S) Hereby Confirms the Assignment.
Apr 17, 2025
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 070887/0702 →
Corrective Assignment to Correct the Incorrect Patent Application Number 18/315,521 with Correct Patent Application Number 18/315,351 Previously Recorded on Reel 67198 Frame 598. Assignor(S) Hereby Confirms the Assignment of Assignors Interest.
Apr 17, 2025
From: ENDO GLOBAL AESTHETICS LIMITED
To: PALADIN PHARMA INC.
Reel/Frame 070887/0742 →